Provided by Tiger Trade Technology Pte. Ltd.

Virpax Pharmaceuticals, Inc.

0.0107
-0.0004-3.60%
Volume:111.00
Turnover:1.16
Market Cap:13.29K
PE:0.00
High:0.0107
Open:0.0107
Low:0.0107
Close:0.0111
52wk High:11.75
52wk Low:0.0000
Shares:1.24M
Float Shares:1.23M
Volume Ratio:0.31
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-70.9103
EPS(LYR):-70.9103
ROE:-2364.82%
ROA:-135.01%
PB:-0.01
PE(LYR):0.00

Loading ...

BUZZ-Virpax Pharma plunges as Nasdaq delisting looms

Reuters
·
Apr 03, 2025

Virpax Pharmaceuticals Inc - Usama Chaudhry Resigns as CFO - SEC Filing

THOMSON REUTERS
·
Apr 03, 2025

Virpax Pharmaceuticals Inc - Nasdaq to File Form 25 for Virpax Pharmaceuticals Delisting

THOMSON REUTERS
·
Apr 03, 2025

Virpax Pharmaceuticals : Does Not Intend to Request Review of Panel's Decision by Nasdaq Listing and Hearing Review Council

THOMSON REUTERS
·
Apr 03, 2025

BRIEF-Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock

Reuters
·
Mar 25, 2025

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Rate Decision

MT Newswires Live
·
Mar 19, 2025

Virpax Pharmaceuticals Announces Reverse Stock Split

THOMSON REUTERS
·
Mar 19, 2025

Virpax Pharmaceuticals Inc - to Effect 1-for-25 Reverse Stock Split

THOMSON REUTERS
·
Mar 19, 2025

Virpax Reports Positive Results From Dose Range Finding Study of Pain Relief Treatment in Beagle Dogs

MT Newswires Live
·
Mar 19, 2025

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in Ind

THOMSON REUTERS
·
Mar 19, 2025

Virpax Pharmaceuticals Inc - Doses of Lbl100 up to 90 Mg/Kg Well Tolerated by Beagle Dogs

THOMSON REUTERS
·
Mar 19, 2025

BRIEF-Virpax Looking To Use Met To Develop Intranasal Covid Vaccine

Reuters
·
Mar 07, 2025

Virpax Pharmaceuticals Inc - to Explore Intranasal Vaccine Delivery

THOMSON REUTERS
·
Mar 07, 2025

Virpax Looking to Use Met to Develop Intranasal Covid Vaccine

THOMSON REUTERS
·
Mar 07, 2025